PUBLISHER: IMARC | PRODUCT CODE: 1467738
PUBLISHER: IMARC | PRODUCT CODE: 1467738
The global spinal implants and surgery devices market size reached US$ 11.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.
Spinal implants and surgery devices refer to the medical equipment used to treat spinal deformities and disorders. These implants are manufactured using biocompatible materials, such as titanium, titanium-alloy and stainless-steel, and are commonly available in two variants, namely fusion and non-fusion implants. Fusion implants include rods, plates, screws and interbody cages. On the other hand, non-fusion implants include artificial discs, expandable rods and growth sparing devices. Apart from this, thoracic, lumbar and cervical fusion and spinal decompression devices are also used for various treatment procedures. These implants are used to facilitate the movement of two vertebrae, improve the stability of the spine and correct deformities.
The increasing prevalence of spinal disorders, such as degenerative disc disease, scoliosis, kyphosis and spondylolisthesis, is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the majority of the working population, which, in turn, is significantly increasing the incidences of obesity, back pain, posture-related problems and other degenerative spinal conditions. Furthermore, the development of efficient growth-sparing devices, which are specifically designed for patients, especially children, who have not reached skeletal maturity is also contributing to the market growth. Additionally, various technological advancements, such as the development of advanced bone grafting products and the utilization of materials that are more durable than metal, are favoring the growth of the market. Other factors, including the rising geriatric population and widespread adoption of minimally invasive (MI) spinal surgeries, are expected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global spinal implants and surgery devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, type of surgery, and end user.
Thoracic Fusion and Lumbar Fusion Devices
Cervical Fusion Devices
Spine Biologics
Vertebral Compression Fracture Treatment Devices
Spinal Decompression Devices
Non-Fusion Devices
Spine Bone Stimulators
Open Surgeries
Minimally Invasive Surgeries
Hospitals
Ambulatory Surgery Centers
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, B. Braun (B. Braun Holding GmbH & Co. KG), Boston Scientific, Depuy Synthes (Johnson & Johnson), Exactech Inc. (Choice Spine), Globus Medical Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Nuvasive Inc. (Smith & Nephew Plc), Orthofix Medical Inc., RTI Surgical Inc., Stryker Corporation and Zimmer Biomet Holdings Inc.